MYRIAD GENETICS INC - COM (MYGN)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
90.7M
Holdings value Q3 2024
$2.48B
Value change Q3 2024
-$46.7M
Grand Portfolio weight change Q3 2024
0%
Number of holders
241
Number of buys Q3 2024
127
Number of sells Q3 2024
-94
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 90.7M $2.48B -$46.7M $27.39 241
2024 Q2 92.3M $2.26B -$38.9M $24.46 221
2024 Q1 93.8M $2B +$85.6M $21.32 185
2023 Q4 89.9M $1.72B +$139M $19.14 192
2023 Q3 82.7M $1.33B +$18.8M $16.04 183
2023 Q2 81.1M $1.88B -$25.4M $23.18 183
2023 Q1 82.2M $1.91B +$45.2M $23.23 186
2022 Q4 80.5M $1.17B -$18.9M $14.51 190
2022 Q3 81.5M $1.55B +$26.2M $19.08 185
2022 Q2 79.9M $1.45B +$19.1M $18.17 188
2022 Q1 78.9M $1.99B +$13.4M $25.20 199
2021 Q4 78.3M $2.16B -$41.8M $27.60 193
2021 Q3 79.3M $2.56B +$122M $32.29 211
2021 Q2 75.5M $2.31B +$49.3M $30.58 199
2021 Q1 73.9M $2.25B -$35.1M $30.45 193
2020 Q4 75M $1.48B +$38M $19.78 178
2020 Q3 78.4M $1.02B +$20M $13.04 186
2020 Q2 72.9M $827M -$35.2M $11.34 190
2020 Q1 73.5M $1.05B -$123M $14.31 182
2019 Q4 78.8M $2.15B +$33.4M $27.23 222
2019 Q3 77.5M $2.22B +$28.1M $28.63 220
2019 Q2 76.9M $2.13B -$66.2M $27.78 234
2019 Q1 78.6M $2.61B +$98.3M $33.20 259
2018 Q4 76.3M $2.22B +$6.25M $29.07 259
2018 Q3 75.4M $3.47B +$112M $46.00 281
2018 Q2 73.3M $2.74B -$57.2M $37.37 250
2018 Q1 75.1M $2.22B +$16M $29.55 255
2017 Q4 74.7M $2.57B -$23.8M $34.34 248
2017 Q3 74.5M $2.69B -$243M $36.18 213
2017 Q2 82M $2.12B -$22.1M $25.84 236
2017 Q1 83.6M $1.61B +$174M $19.20 230
2016 Q4 80.7M $1.35B -$63.2M $16.67 220
2016 Q3 82.7M $1.7B -$42.4M $20.58 217
2016 Q2 81.1M $2.48B -$32.4M $30.60 250
2016 Q1 81.8M $3.06B -$306M $37.43 228
2015 Q4 89.6M $3.87B -$55.8M $43.16 227
2015 Q3 90.4M $3.39B -$55.2M $37.48 228
2015 Q2 92.8M $3.15B -$17.8M $33.99 233
2015 Q1 92.6M $3.28B -$58.4M $35.40 250
2014 Q4 93.7M $3.19B -$80.6M $34.06 263
2014 Q3 95.4M $3.68B -$224M $38.57 270
2014 Q2 101M $3.94B -$222M $38.92 280
2014 Q1 108M $3.7B +$249M $34.19 276